Alkermes (ALKS) Accumulated Expenses (2012 - 2026)
Alkermes (ALKS) posted quarterly Accumulated Expenses of $295.6 million for Q2 2026, up 16.78% year-over-year from $253.2 million in Q2 2025, and up 8.36% quarter-over-quarter from $272.8 million in Q1 2026.
Alkermes (ALKS) Accumulated Expenses (2012 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Accumulated Expenses for 15 consecutive years, with $295.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accumulated Expenses rose 16.78% year-over-year to $295.6 million; the TTM figure through Jun 2026 stood at $295.6 million (up 16.78% YoY), while the FY2025 annual figure was $247.1 million, down 9.3% from the prior year.
- Accumulated Expenses rose to $295.6 million in Q2 2026 per ALKS's latest filing, from $272.8 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $295.6 million in Q2 2026 and bottomed at $222.8 million in Q2 2023.
- Historically, Accumulated Expenses has averaged $256.6 million across 5 years, with a median of $253.0 million in 2025.
- Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 38.75% — and 2024, when it retreated 14.66%.
- Alkermes' Accumulated Expenses stood at $252.1 million in 2022, then increased by 4.57% to $263.6 million in 2023, then rose by 3.34% to $272.5 million in 2024, then declined by 9.3% to $247.1 million in 2025, then rose by 19.63% to $295.6 million in 2026.
- Business Quant data shows ALKS's Accumulated Expenses at $295.6 million in Q2 2026, $272.8 million in Q1 2026, and $247.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 295.65 Mn |
| Mar 31, 2026 | 272.84 Mn |
| Dec 31, 2025 | 247.13 Mn |
| Sep 30, 2025 | 252.74 Mn |
| Jun 30, 2025 | 253.17 Mn |
| Mar 31, 2025 | 249.80 Mn |
| Dec 31, 2024 | 272.45 Mn |
| Sep 30, 2024 | 282.02 Mn |
| Jun 30, 2024 | 263.46 Mn |
| Mar 31, 2024 | 240.88 Mn |
| Dec 31, 2023 | 263.64 Mn |
| Sep 30, 2023 | 238.47 Mn |
| Jun 30, 2023 | 222.77 Mn |
| Mar 31, 2023 | 282.26 Mn |
| Dec 31, 2022 | 252.12 Mn |
| Sep 30, 2022 | 235.64 Mn |
| Jun 30, 2022 | 228.97 Mn |
| Mar 31, 2022 | 265.17 Mn |
| Dec 31, 2021 | 237.22 Mn |
| Sep 30, 2021 | 221.72 Mn |